Medicines360 Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEDICINES360, and what generic alternatives to MEDICINES360 drugs are available?
MEDICINES360 has one approved drug.
There are three US patents protecting MEDICINES360 drugs.
There are thirty-three patent family members on MEDICINES360 drugs in nineteen countries and nine supplementary protection certificates in nine countries.
Drugs and US Patents for Medicines360
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medicines360 | LILETTA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | 11,090,186 | ⤷ Sign Up | ⤷ Sign Up | ||||
Medicines360 | LILETTA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | 11,571,328 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Medicines360 | LILETTA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | 10,028,858 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Medicines360 | LILETTA | levonorgestrel | INTRAUTERINE DEVICE;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Medicines360 Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Brazil | 112020019403 | ⤷ Sign Up |
European Patent Office | 3773370 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2013009674 | ⤷ Sign Up |
Spain | 2694173 | ⤷ Sign Up |
South Korea | 20140051296 | ⤷ Sign Up |
Japan | 2021518216 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Medicines360 Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1453521 | 39/2015 | Austria | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1453521 | CA 2016 00016 | Denmark | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
1453521 | 93156 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 |
1453521 | C201630040 | Spain | ⤷ Sign Up | PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211 |
1453521 | 15C0050 | France | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
1453521 | C 2015 029 | Romania | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL SI ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: RO 7793/2015/001; DATE OF NATIONAL AUTHORISATION: 20150612; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SK. 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150129 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.